Glutamine supplementation promotes anaplerosis but not oxidative energy delivery in human skeletal muscle
1 Human Muscle Metabolism Research Group, Loughborough University, Loughborough LE11 3TU; 2 School of Biomedical Sciences, Queens Medical Centre, Nottingham NG7 2UH; 3 Sunderland Royal Hospital, Sunderland SR4 7TP; and 4 Sport and Exercise Research Centre, South Bank University, London SE1 0AA,...
Saved in:
Published in | American journal of physiology: endocrinology and metabolism Vol. 280; no. 4; pp. E669 - E675 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.04.2001
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 1 Human Muscle Metabolism Research Group, Loughborough
University, Loughborough LE11 3TU; 2 School of Biomedical
Sciences, Queens Medical Centre, Nottingham NG7 2UH;
3 Sunderland Royal Hospital, Sunderland SR4 7TP; and
4 Sport and Exercise Research Centre, South Bank University,
London SE1 0AA, United Kingdom
The aims of the present
study were twofold: first to investigate whether TCA cycle intermediate
(TCAI) pool expansion at the onset of moderate-intensity exercise in
human skeletal muscle could be enhanced independently of pyruvate
availability by ingestion of glutamine or ornithine -ketoglutarate,
and second, if it was, whether this modification of TCAI pool expansion
had any effect on oxidative energy status during subsequent exercise.
Seven males cycled for 10 min at ~70% maximal O 2 uptake
1 h after consuming either an artificially sweetened placebo (5 ml/kg body wt solution, CON), 0.125 g/kg body wt
L- (+)-ornithine -ketoglutarate dissolved in 5 ml/kg body
wt solution (OKG), or 0.125 g/kg body wt L -glutamine dissolved in 5 ml/kg body wt solution (GLN). Vastus lateralis muscle
was biopsied 1 h postsupplement and after 10 min of exercise. The
sum of four measured TCAI ( TCAI; citrate, malate, fumarate, and
succinate, ~85% of total TCAI pool) was not different between conditions 1 h postsupplement. However, after 10 min of exercise, TCAI (mmol/kg dry muscle) was greater in the GLN condition
(4.90 ± 0.61) than in the CON condition (3.74 ± 0.38, P < 0.05) and the OKG condition (3.85 ± 0.28).
After 10 min of exercise, muscle phosphocreatine (PCr) content was
significantly reduced ( P < 0.05) in all conditions,
but there was no significant difference between conditions. We conclude
that the ingestion of glutamine increased TCAI pool size after 10 min
of exercise most probably because of the entry of glutamine carbon at
the level of -ketoglutarate. However, this increased expansion in
the TCAI pool did not appear to increase oxidative energy production,
because there was no sparing of PCr during exercise.
tricarboxylic acid cycle intermediates; exercise; glutamate; phosphocreatine |
---|---|
AbstractList | The aims of the present study were twofold: first to investigate whether TCA cycle intermediate (TCAI) pool expansion at the onset of moderate-intensity exercise in human skeletal muscle could be enhanced independently of pyruvate availability by ingestion of glutamine or ornithine alpha-ketoglutarate, and second, if it was, whether this modification of TCAI pool expansion had any effect on oxidative energy status during subsequent exercise. Seven males cycled for 10 min at approximately 70% maximal O2) uptake 1 h after consuming either an artificially sweetened placebo (5 ml/kg body wt solution, CON), 0.125 g/kg body wt L-(+)-ornithine alpha-ketoglutarate dissolved in 5 ml/kg body wt solution (OKG), or 0.125 g/kg body wt L-glutamine dissolved in 5 ml/kg body wt solution (GLN). Vastus lateralis muscle was biopsied 1 h postsupplement and after 10 min of exercise. The sum of four measured TCAI (SigmaTCAI; citrate, malate, fumarate, and succinate, approximately 85% of total TCAI pool) was not different between conditions 1 h postsupplement. However, after 10 min of exercise, SigmaTCAI (mmol/kg dry muscle) was greater in the GLN condition (4.90 +/- 0.61) than in the CON condition (3.74 +/- 0.38, P < 0.05) and the OKG condition (3.85 +/- 0.28). After 10 min of exercise, muscle phosphocreatine (PCr) content was significantly reduced (P < 0.05) in all conditions, but there was no significant difference between conditions. We conclude that the ingestion of glutamine increased TCAI pool size after 10 min of exercise most probably because of the entry of glutamine carbon at the level of alpha-ketoglutarate. However, this increased expansion in the TCAI pool did not appear to increase oxidative energy production, because there was no sparing of PCr during exercise. 1 Human Muscle Metabolism Research Group, Loughborough University, Loughborough LE11 3TU; 2 School of Biomedical Sciences, Queens Medical Centre, Nottingham NG7 2UH; 3 Sunderland Royal Hospital, Sunderland SR4 7TP; and 4 Sport and Exercise Research Centre, South Bank University, London SE1 0AA, United Kingdom The aims of the present study were twofold: first to investigate whether TCA cycle intermediate (TCAI) pool expansion at the onset of moderate-intensity exercise in human skeletal muscle could be enhanced independently of pyruvate availability by ingestion of glutamine or ornithine -ketoglutarate, and second, if it was, whether this modification of TCAI pool expansion had any effect on oxidative energy status during subsequent exercise. Seven males cycled for 10 min at ~70% maximal O 2 uptake 1 h after consuming either an artificially sweetened placebo (5 ml/kg body wt solution, CON), 0.125 g/kg body wt L- (+)-ornithine -ketoglutarate dissolved in 5 ml/kg body wt solution (OKG), or 0.125 g/kg body wt L -glutamine dissolved in 5 ml/kg body wt solution (GLN). Vastus lateralis muscle was biopsied 1 h postsupplement and after 10 min of exercise. The sum of four measured TCAI ( TCAI; citrate, malate, fumarate, and succinate, ~85% of total TCAI pool) was not different between conditions 1 h postsupplement. However, after 10 min of exercise, TCAI (mmol/kg dry muscle) was greater in the GLN condition (4.90 ± 0.61) than in the CON condition (3.74 ± 0.38, P < 0.05) and the OKG condition (3.85 ± 0.28). After 10 min of exercise, muscle phosphocreatine (PCr) content was significantly reduced ( P < 0.05) in all conditions, but there was no significant difference between conditions. We conclude that the ingestion of glutamine increased TCAI pool size after 10 min of exercise most probably because of the entry of glutamine carbon at the level of -ketoglutarate. However, this increased expansion in the TCAI pool did not appear to increase oxidative energy production, because there was no sparing of PCr during exercise. tricarboxylic acid cycle intermediates; exercise; glutamate; phosphocreatine The aims of the present study were twofold: first to investigate whether TCA cycle intermediate (TCAI) pool expansion at the onset of moderate-intensity exercise in human skeletal muscle could be enhanced independently of pyruvate availability by ingestion of glutamine or ornithine α-ketoglutarate, and second, if it was, whether this modification of TCAI pool expansion had any effect on oxidative energy status during subsequent exercise. Seven males cycled for 10 min at ∼70% maximal O 2 uptake 1 h after consuming either an artificially sweetened placebo (5 ml/kg body wt solution, CON), 0.125 g/kg body wtl-(+)-ornithine α-ketoglutarate dissolved in 5 ml/kg body wt solution (OKG), or 0.125 g/kg body wt l-glutamine dissolved in 5 ml/kg body wt solution (GLN). Vastus lateralis muscle was biopsied 1 h postsupplement and after 10 min of exercise. The sum of four measured TCAI (ΣTCAI; citrate, malate, fumarate, and succinate, ∼85% of total TCAI pool) was not different between conditions 1 h postsupplement. However, after 10 min of exercise, ΣTCAI (mmol/kg dry muscle) was greater in the GLN condition (4.90 ± 0.61) than in the CON condition (3.74 ± 0.38, P < 0.05) and the OKG condition (3.85 ± 0.28). After 10 min of exercise, muscle phosphocreatine (PCr) content was significantly reduced ( P < 0.05) in all conditions, but there was no significant difference between conditions. We conclude that the ingestion of glutamine increased TCAI pool size after 10 min of exercise most probably because of the entry of glutamine carbon at the level of α-ketoglutarate. However, this increased expansion in the TCAI pool did not appear to increase oxidative energy production, because there was no sparing of PCr during exercise. The aims of the present study were twofold: first to investigate whether TCA cycle intermediate (TCAI) pool expansion at the onset of moderate-intensity exercise in human skeletal muscle could be enhanced independently of pyruvate availability by ingestion of glutamine or ornithine alpha-ketoglutarate, and second, if it was, whether this modification of TCAI pool expansion had any effect on oxidative energy status during subsequent exercise. Seven males cycled for 10 min at approximately 70% maximal O2) uptake 1 h after consuming either an artificially sweetened placebo (5 ml/kg body wt solution, CON), 0.125 g/kg body wt L-(+)-ornithine alpha-ketoglutarate dissolved in 5 ml/kg body wt solution (OKG), or 0.125 g/kg body wt L-glutamine dissolved in 5 ml/kg body wt solution (GLN). Vastus lateralis muscle was biopsied 1 h postsupplement and after 10 min of exercise. The sum of four measured TCAI (SigmaTCAI; citrate, malate, fumarate, and succinate, approximately 85% of total TCAI pool) was not different between conditions 1 h postsupplement. However, after 10 min of exercise, SigmaTCAI (mmol/kg dry muscle) was greater in the GLN condition (4.90 +/- 0.61) than in the CON condition (3.74 +/- 0.38, P < 0.05) and the OKG condition (3.85 +/- 0.28). After 10 min of exercise, muscle phosphocreatine (PCr) content was significantly reduced (P < 0.05) in all conditions, but there was no significant difference between conditions. We conclude that the ingestion of glutamine increased TCAI pool size after 10 min of exercise most probably because of the entry of glutamine carbon at the level of alpha-ketoglutarate. However, this increased expansion in the TCAI pool did not appear to increase oxidative energy production, because there was no sparing of PCr during exercise. The aims of the present study were twofold: first to investigate whether TCA cycle intermediate (TCAI) pool expansion at the onset of moderate-intensity exercise in human skeletal muscle could be enhanced independently of pyruvate availability by ingestion of glutamine or ornithine alpha -ketoglutarate, and second, if it was, whether this modification of TCAI pool expansion had any effect on oxidative energy status during subsequent exercise. Seven males cycled for 10 min at similar to 70% maximal O sub(2) uptake 1 h after consuming either an artificially sweetened placebo (5 ml/kg body wt solution, CON), 0.125 g/kg body wt L-(+)-ornithine alpha -ketoglutarate dissolved in 5 ml/kg body wt solution (OKG), or 0.125 g/kg body wt L-glutamine dissolved in 5 ml/kg body wt solution (GLN). Vastus lateralis muscle was biopsied 1 h postsupplement and after 10 min of exercise. The sum of four measured TCAI ( capital sigma TCAI; citrate, malate, fumarate, and succinate, similar to 85% of total TCAI pool) was not different between conditions 1 h postsupplement. However, after 10 min of exercise, capital sigma TCAI (mmol/kg dry muscle) was greater in the GLN condition (4.90 plus or minus 0.61) than in the CON condition (3.74 plus or minus 0.38, P < 0.05) and the OKG condition (3.85 plus or minus 0.28). After 10 min of exercise, muscle phosphocreatine (PCr) content was significantly reduced (P < 0.05) in all conditions, but there was no significant difference between conditions. We conclude that the ingestion of glutamine increased TCAI pool size after 10 min of exercise most probably because of the entry of glutamine carbon at the level of alpha -ketoglutarate. However, this increased expansion in the TCAI pool did not appear to increase oxidative energy production, because there was no sparing of PCr during exercise. |
Author | Williams, Clyde Greenhaff, Paul L Boobis, Leslie H Bowtell, Joanna L Bruce, Mark Constantin-Teodosiu, Dumitru |
Author_xml | – sequence: 1 fullname: Bruce, Mark – sequence: 2 fullname: Constantin-Teodosiu, Dumitru – sequence: 3 fullname: Greenhaff, Paul L – sequence: 4 fullname: Boobis, Leslie H – sequence: 5 fullname: Williams, Clyde – sequence: 6 fullname: Bowtell, Joanna L |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11254475$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkcFu3CAURVGVqpmk_YWWVXee8mwwZllFSVopUjbpGmH7eYYUg2twG_99iWaqyaZqVwjeuRfEuSBnPngk5AOwLYAoP5nHCX0ftiVjsC0btuVbrGv1imzytCxACHFGNgxUVUDD1Tm5iPGRMSYFL9-Qc4BScC7FhthbtyQzWo80LtPkcESfTLLB02kOY0gYqfEmD-YQbaTtkqgPiYYn22fsJ1L0OO9W2qPLu3ml1tP9MhpP43d0mIyj4xI7h2_J68G4iO-O6yX5dnP9cPWluLu__Xr1-a7ouFCpGFiFXVsNpla1bACllNhWsusUMDa0wLsKOZY9E8qofMplqaDktTA1IoCpLsnHQ29-_48FY9KjjR06ZzyGJWpZqwbqWvwThAa4Kqvmf0CQjeIZlAewy58VZxz0NNvRzKsGpp-96aM3_exNZ2-a6-vsLSffH69Y2hH7U-4oKgPFAdjb3f6XnVFP-zXa4MJuPbW-LFR_528W5x7wKf0JnnJ66ofqN4k-v6M |
CitedBy_id | crossref_primary_10_1111_j_1469_7793_2003_00334_x crossref_primary_10_1113_jphysiol_2002_028084 crossref_primary_10_1152_japplphysiol_00866_2002 crossref_primary_10_1152_japplphysiol_00305_2005 crossref_primary_10_1152_japplphysiol_01344_2003 crossref_primary_10_1016_j_resp_2011_03_010 crossref_primary_10_1113_jphysiol_2004_075713 crossref_primary_10_1113_jphysiol_2004_079939 crossref_primary_10_1136_bjsports_2012_091506 crossref_primary_10_1161_CIRCULATIONAHA_111_067827 crossref_primary_10_1016_j_phanu_2020_100236 crossref_primary_10_1152_japplphysiol_01118_2002 crossref_primary_10_1113_jphysiol_2001_012983 crossref_primary_10_3390_genes13101853 crossref_primary_10_1093_ajcn_83_1_115 crossref_primary_10_1097_00075197_200201000_00013 crossref_primary_10_1007_s00204_021_02974_9 crossref_primary_10_1249_MSS_0b013e3182797637 crossref_primary_10_1007_s00421_006_0324_4 crossref_primary_10_1152_japplphysiol_90394_2008 crossref_primary_10_3389_fnut_2017_00013 crossref_primary_10_1038_s41598_024_51920_z crossref_primary_10_1016_j_clnu_2018_05_001 crossref_primary_10_1172_JCI0215311 crossref_primary_10_5812_hmj_93806 |
Cites_doi | 10.1152/jappl.1989.66.2.561 10.1093/ajcn/65.2.512 10.1152/ajpendo.1993.264.6.E993 10.1042/cs0800625 10.1172/JCI1146 10.1177/0148607192016006505 10.1152/jappl.1999.87.5.1662 10.1016/0014-5793(91)80104-B 10.1007/BF00967243 10.3109/00365516709093481 10.1042/cs0970557 10.1152/ajpendo.2000.278.1.E83 10.1097/00075197-199901000-00007 10.1093/jn/128.3.563 10.1152/ajpendo.1997.272.2.E239 10.1152/jappl.1999.86.2.450 10.1111/j.1748-1716.1987.tb08090.x 10.1152/jappl.1999.86.6.1770 10.1093/ajcn/39.4.514 10.1111/j.1469-7793.1997.703bj.x 10.1152/ajpendo.1995.269.4.E663 10.1079/PNS19920039 10.1152/ajpendo.1995.269.2.E309 10.1111/j.1475-097X.1985.tb00591.x 10.1152/ajpcell.1990.259.5.C834 10.1152/ajpendo.1999.276.3.E472 10.1152/ajpendo.1999.277.1.E33 10.1016/0140-6736(90)90811-I 10.1152/ajpendo.1998.275.2.E235 10.1016/0304-4165(93)90078-M 10.1080/07315724.1990.10720343 10.1152/ajpendo.1993.264.6.E848 10.1152/ajpendo.1999.277.1.E18 10.1111/j.1748-1716.1992.tb09278.x 10.1016/S0899-9007(98)00118-X 10.1016/S0021-9258(17)37934-6 10.3109/00365517509095787 10.1042/cs0880687 10.1152/ajpendo.1991.260.3.E436 10.1152/ajpendo.1998.274.2.E377 10.1016/0021-9673(95)00879-9 10.1042/bj2740769 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TS 7X8 |
DOI | 10.1152/ajpendo.2001.280.4.e669 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Physical Education Index MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Physical Education Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Physical Education Index MEDLINE - Academic Physical Education Index |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1555 |
EndPage | E675 |
ExternalDocumentID | 10_1152_ajpendo_2001_280_4_E669 11254475 ajpendo_280_4_E669 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 23M 2WC 39C 53G 5GY 5VS 8M5 ABPTK ACPRK ADACO ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP C1A DIK DL E3Z EBS F5P GX1 KQ8 O0- OK1 P2P PQEST PQQKQ RAP RHF RHI RPL WH7 WOQ --- 4.4 6J9 AAFWJ ABJNI AFFNX BKKCC BTFSW CGR CUY CVF ECM EIF EJD EMOBN H13 ITBOX NPM P6G RPRKH TR2 W8F XSW YSK AAYXX CITATION 7TS 7X8 |
ID | FETCH-LOGICAL-c459t-f03ecb3fa696781e777eb37cc9100fb14c3e4e2d059a9cc9472912465a6ee11a3 |
ISSN | 0193-1849 |
IngestDate | Fri Oct 25 01:07:35 EDT 2024 Fri Oct 25 04:38:20 EDT 2024 Fri Oct 25 09:53:12 EDT 2024 Thu Sep 12 20:18:35 EDT 2024 Sat Sep 28 08:46:53 EDT 2024 Tue Jan 05 17:54:12 EST 2021 Mon May 06 11:39:46 EDT 2019 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c459t-f03ecb3fa696781e777eb37cc9100fb14c3e4e2d059a9cc9472912465a6ee11a3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 11254475 |
PQID | 18117894 |
PQPubID | 23462 |
ParticipantIDs | crossref_primary_10_1152_ajpendo_2001_280_4_E669 proquest_miscellaneous_18149238 highwire_physiology_ajpendo_280_4_E669 proquest_miscellaneous_18117894 proquest_miscellaneous_76981665 pubmed_primary_11254475 |
PublicationCentury | 2000 |
PublicationDate | 2001-04-01 |
PublicationDateYYYYMMDD | 2001-04-01 |
PublicationDate_xml | – month: 04 year: 2001 text: 2001-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of physiology: endocrinology and metabolism |
PublicationTitleAlternate | Am J Physiol Endocrinol Metab |
PublicationYear | 2001 |
References | B20 B42 B43 B22 B44 B23 B45 B24 B46 Edwards RM (B13) 1997; 281 B26 B29 Lee SH (B27) 1979; 254 Grimble GK (B21) 1992; 51 B30 B31 B10 B32 B11 Le Boucher J (B25) 1998; 14 B33 B12 B34 B35 B14 B36 B15 B37 B16 B38 B17 B39 B18 B19 B1 B3 B4 Lindena J (B28) 1986; 24 B5 B6 B7 B9 B40 B41 |
References_xml | – ident: B19 doi: 10.1152/jappl.1989.66.2.561 – ident: B26 doi: 10.1093/ajcn/65.2.512 – ident: B1 doi: 10.1152/ajpendo.1993.264.6.E993 – ident: B31 doi: 10.1042/cs0800625 – ident: B40 doi: 10.1172/JCI1146 – volume: 24 start-page: 35 year: 1986 ident: B28 publication-title: J Clin Chem Clin Biochem contributor: fullname: Lindena J – ident: B46 doi: 10.1177/0148607192016006505 – ident: B14 doi: 10.1152/jappl.1999.87.5.1662 – ident: B6 doi: 10.1016/0014-5793(91)80104-B – ident: B35 doi: 10.1007/BF00967243 – volume: 281 start-page: 1059 year: 1997 ident: B13 publication-title: J Pharmacol Exp Ther contributor: fullname: Edwards RM – ident: B24 doi: 10.3109/00365516709093481 – ident: B41 doi: 10.1042/cs0970557 – ident: B20 doi: 10.1152/ajpendo.2000.278.1.E83 – ident: B9 doi: 10.1097/00075197-199901000-00007 – ident: B12 doi: 10.1093/jn/128.3.563 – ident: B18 doi: 10.1152/ajpendo.1997.272.2.E239 – ident: B37 doi: 10.1152/jappl.1999.86.2.450 – ident: B34 doi: 10.1111/j.1748-1716.1987.tb08090.x – ident: B5 doi: 10.1152/jappl.1999.86.6.1770 – ident: B11 doi: 10.1093/ajcn/39.4.514 – ident: B15 doi: 10.1111/j.1469-7793.1997.703bj.x – ident: B22 doi: 10.1152/ajpendo.1995.269.4.E663 – volume: 51 start-page: 119A year: 1992 ident: B21 publication-title: Proc Nutr Soc doi: 10.1079/PNS19920039 contributor: fullname: Grimble GK – ident: B42 doi: 10.1152/ajpendo.1995.269.2.E309 – ident: B4 doi: 10.1111/j.1475-097X.1985.tb00591.x – ident: B33 doi: 10.1152/ajpcell.1990.259.5.C834 – ident: B7 doi: 10.1152/ajpendo.1999.276.3.E472 – ident: B17 doi: 10.1152/ajpendo.1999.277.1.E33 – ident: B44 doi: 10.1016/0140-6736(90)90811-I – ident: B16 doi: 10.1152/ajpendo.1998.275.2.E235 – ident: B38 doi: 10.1016/0304-4165(93)90078-M – ident: B10 doi: 10.1080/07315724.1990.10720343 – ident: B29 doi: 10.1152/ajpendo.1993.264.6.E848 – ident: B23 doi: 10.1152/ajpendo.1999.277.1.E18 – ident: B43 doi: 10.1111/j.1748-1716.1992.tb09278.x – volume: 14 start-page: 870 year: 1998 ident: B25 publication-title: Nutrition doi: 10.1016/S0899-9007(98)00118-X contributor: fullname: Le Boucher J – volume: 254 start-page: 420 year: 1979 ident: B27 publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)37934-6 contributor: fullname: Lee SH – ident: B3 doi: 10.3109/00365517509095787 – ident: B32 doi: 10.1042/cs0880687 – ident: B36 doi: 10.1152/ajpendo.1991.260.3.E436 – ident: B39 doi: 10.1152/ajpendo.1998.274.2.E377 – ident: B30 doi: 10.1016/0021-9673(95)00879-9 – ident: B45 doi: 10.1042/bj2740769 |
SSID | ssj0007542 |
Score | 1.859089 |
Snippet | 1 Human Muscle Metabolism Research Group, Loughborough
University, Loughborough LE11 3TU; 2 School of Biomedical
Sciences, Queens Medical Centre, Nottingham... The aims of the present study were twofold: first to investigate whether TCA cycle intermediate (TCAI) pool expansion at the onset of moderate-intensity... |
SourceID | proquest crossref pubmed highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | E669 |
SubjectTerms | Adult Amino Acids - blood Amino Acids - metabolism Bicycling Citric Acid Cycle - physiology Energy Metabolism - drug effects Glutamine - pharmacology Humans Male Muscle, Skeletal - drug effects Muscle, Skeletal - metabolism Ornithine - analogs & derivatives Ornithine - pharmacology Oxidation-Reduction Phosphocreatine - metabolism |
Title | Glutamine supplementation promotes anaplerosis but not oxidative energy delivery in human skeletal muscle |
URI | http://ajpendo.physiology.org/cgi/content/abstract/280/4/E669 https://www.ncbi.nlm.nih.gov/pubmed/11254475 https://search.proquest.com/docview/18117894 https://search.proquest.com/docview/18149238 https://search.proquest.com/docview/76981665 |
Volume | 280 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuK9jlUZ4-oL1UKU1i53FcVl1WUJZFSqXeLCdxRGCbVJtEAv4F_5ixHScpbHldosqNx2nniz1jz3yD0AsS2pwEqWclGacWiTPHkuW3LYcLN5AM6E6i2D7PvbMlebOiq9Ho-yBqqanjafLt2ryS_9EqtIFeZZbsP2i2EwoN8Bn0C1fQMFz_SsevQThfSzuxksU5dSC4UuhGRdkJScDM4QtYCvNqEjf1pCjrSfklTzXft9CZf6m4lOEZKgVQF-2rPsNyJPMk101lBjVcteaMZ0A6ofZHdN6LrPRTpCVMRkVP77QGWXF5aegKlfvfJGJrN_ZEW6p1XliRAGe5yputiGQVIfSRaxbJi0m3af2qLGNNlLBoMy3MJoY9iH1p9zVD1wJnMxxOzI6u8dQikAym2bmn67u0S_bc09VXfl0OqKSX5Z9kOWGV6WlPQeiUTEUnYEjAff6enS4XCxbNV9ENdNOBuUtGCb790BPQy4LBOgNfP28bMggDvdwxzLbBY0iodzs0yrCJ7qD91iPBxxped9FIFAfo8Ljgdbn-io_wRafbA3TrXRuKcYjyDnz4J_BhAz48AB8G8GEAH-7AhzX4sAEfzguswIcN-LAG3z20PJ1HJ2dWW7fDSggNayubuSKJ3Yx7IZhCtvB9X8SunyRgms6y2CaJK4hwUrDseQitBBw8MDM9yj0hbJu799FeURbiIcJ-Rn0xi0PfzcCV51mQuLHjCRrwGaVJFozRzPy5bKPpWZhya6nDWn3IQqs2A30wwiRuxsgxSmD928Hkjk8EaDDd-g5sk2ZjdHRdp26IgfTnRq8MJmp5-sYLUTYVs2VKdxCS394h6RKD3Xf4XijP-ekYPdCQ6X-0LbkGffroj9Ifo9v9G_gE7dVXjXgKhnUdP1NQ_wFnZdhS |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glutamine+supplementation+promotes+anaplerosis+but+not+oxidative+energy+delivery+in+human+skeletal+muscle&rft.jtitle=American+journal+of+physiology%3A+endocrinology+and+metabolism&rft.au=Bruce%2C+M&rft.au=Constantin-Teodosiu%2C+D&rft.au=Greenhaff%2C+P+L&rft.au=Boobis%2C+L+H&rft.date=2001-04-01&rft.issn=0193-1849&rft.volume=280&rft.issue=4&rft.spage=E669&rft.epage=E675&rft_id=info:doi/10.1152%2Fajpendo.2001.280.4.e669&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0193-1849&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0193-1849&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0193-1849&client=summon |